"Expanding knowledge and access
to emergency contraception"
"Expanding knowledge and access to emergency contraception in Europe"
These posts appear under the ‘Latest News’ heading.
January 2025. A study by the Federal University of Minas Gerais (Belo Horizonte) aimed to estimate use of emergency contraception (EC) among Brazilian adolescent students, as well as the association of individual, family, and community factors with use. A cross-sectional study was carried out, including 38,779 Brazilian adolescent students, aged 13 to 17 years, participating…
December 2024. The marketing authorisation for Esmya was withdrawn in July from the European Economic Area and Belarus, Moldova, Serbia, Ukraine and the United Kingdom, at the request of the marketing-authorisation holder. (See announcement on the European’s Medicines Agency’s website here). The withdrawal was due to commercial reasons and there is no change in the safety…
November 2024. The Study Lucía: Uses and preferences of contraceptive methods in women aged 15 to 49 years in Argentina, was recently published. This quantitative and qualitative research has consulted 2,000 women and people identifyin as LGTB from all over the nation. The study findings, published in September 2024, include valuable information about access to…
November 2024. More than 11,000 prescriptions for emergency contraceptive (EC) pills have been issued since the introduction, last May, of the pilot program “Pharmaceutical Prescription Regulation for Emergency Contraception” (see https://www.ec-ec.org/poland-pilot-program-for-pharmacy-prescribing-of-ecps/). Sales of emergency contraception showed marked increases, according to the Supreme Chamber of Pharmacy: “Analysing market data from the implemented pilot, we observe a…
October 2024. The Central Drugs Standard Control Organization (CDSCO) clarified that emergency contraception pills (ECPs) will remain accessible without prescription in India, and that misinterpretations have led to confusion about prescription requirements for certain hormonal contraceptives. Read more here. In past few weeks, some news reported that a ban on over-the-counter sales of ECPs was…
October 2024. According to local news, in India the Central Drugs Standard Control Organisation (CDSCO) is considering recommending a ban on over-the-counter sales of emergency contraceptive pills (ECPs). The reason suggested for the ban is that what is considered “ an irrational and excessive use” of the ECPs might lead to health complications for women,…
September 2024. In Spain, almost 40% of women of reproductive age report having used emergency contraception pills (ECPs) at least once in their lifetime. Ever use of ECPs is more frequent among women 25 to 39 years of age, and particularly in the age range of 30 to 34, which is also the population with…
September 2024. ASTRA Network (www.astra.org.pl) and the European Consortium for Emergency Contraception presented their latest research findings at the 15th FIAPAC Conference 2024, which was held in Brussels on September 20-21. This collaborative research looked into the cost of emergency contraception pills (ECPs) in select European countries. Our findings show significant disparities across the region,…
July 2024. The World Health Organization (WHO)/HRP just published Implementation of self-care interventions for health and well-being: guidance for health systems. Aimed at those around the world implementing self-care interventions, the publication reviews WHO’s six health systems building blocks, and looks at the implementation considerations necessary for each. Several country case studies are also included….
July 2024. The Royal Pharmaceutical Society (RPS), the Company Chemists’ Association, the National Pharmacy Association and the Faculty of Sexual and Reproductive Healthcare are calling for the next government to commission a national Emergency Hormonal Contraception (EHC) service from community pharmacies in England, similar to current arrangements in Scotland and Wales. Theses organizations demand a National Emergency…
July 2024. In Massachusetts, a standing order policy was introduced in August 2022, to remove barriers to contraceptive prescription. The standing order allows pharmacists to prescribe ulipristal acetate ECPs (which are prescription-only in the US) and LNG ECPs (which are OTC). A study, by Qato et al., aimed at evaluating the association of this policy…
July 2024. The Reproductive Health Supplies Coalition (RHSC) just published the Contraceptive Social Marketing Statistics Report 2023. The report (which to date has been published by DKT) aggregates last year’s sales data for contraceptives and safe abortion supplies of Social Marketing programs in low- and middle-income countries (LMICs) worldwide. Regarding emergency contraception, over 39 million…
Menú
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy
